Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II
Site Search
Site Search
Displaying results 21 - 30 of 100
17/01/2023
Research from IMI project PERISCOPE adds to picture of how infections and vaccines influence immune response.
Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
IMI projects contributed significantly to the development of Ebola vaccines and diagnostic tests.
Bringing a prophylactic Ebola vaccine to licensure
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
Vaccine lot to vaccine lot comparison by consistency testing
Antimicrobial Resistance Accelerator
Pan Ebola vaccine innovative approach
